These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 38811534)
21. The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. van Passel MW; Kant R; Zoetendal EG; Plugge CM; Derrien M; Malfatti SA; Chain PS; Woyke T; Palva A; de Vos WM; Smidt H PLoS One; 2011 Mar; 6(3):e16876. PubMed ID: 21390229 [TBL] [Abstract][Full Text] [Related]
22. Characterization of three novel β-galactosidases from Akkermansia muciniphila involved in mucin degradation. Kosciow K; Deppenmeier U Int J Biol Macromol; 2020 Apr; 149():331-340. PubMed ID: 31991210 [TBL] [Abstract][Full Text] [Related]
23. A previously uncharacterized O-glycopeptidase from Akkermansia muciniphila requires the Tn-antigen for cleavage of the peptide bond. Medley BJ; Leclaire L; Thompson N; Mahoney KE; Pluvinage B; Parson MAH; Burke JE; Malaker S; Wakarchuk W; Boraston AB J Biol Chem; 2022 Oct; 298(10):102439. PubMed ID: 36049519 [TBL] [Abstract][Full Text] [Related]
24. Mutagenesis reveals how Akkermansia muciniphila degrades mucin and colonizes the gut. Nat Microbiol; 2023 Aug; 8(8):1384-1385. PubMed ID: 37344658 [No Abstract] [Full Text] [Related]
25. In vitro co-metabolism of epigallocatechin-3-gallate (EGCG) by the mucin-degrading bacterium Akkermansia muciniphila. Xia Y; Zhang X; Jiang M; Zhang H; Wang Y; Zhang Y; Seviour R; Kong Y PLoS One; 2021; 16(12):e0260757. PubMed ID: 34855864 [TBL] [Abstract][Full Text] [Related]
26. Mucin degradation niche as a driver of microbiome composition and Akkermansia muciniphila abundance in a dynamic gut model is donor independent. Van Herreweghen F; De Paepe K; Roume H; Kerckhof FM; Van de Wiele T FEMS Microbiol Ecol; 2018 Dec; 94(12):. PubMed ID: 30239657 [TBL] [Abstract][Full Text] [Related]
27. Mucin-type O-glycans and their roles in intestinal homeostasis. Bergstrom KS; Xia L Glycobiology; 2013 Sep; 23(9):1026-37. PubMed ID: 23752712 [TBL] [Abstract][Full Text] [Related]
28. Genomic convergence between Akkermansia muciniphila in different mammalian hosts. Geerlings SY; Ouwerkerk JP; Koehorst JJ; Ritari J; Aalvink S; Stecher B; Schaap PJ; Paulin L; de Vos WM; Belzer C BMC Microbiol; 2021 Oct; 21(1):298. PubMed ID: 34715771 [TBL] [Abstract][Full Text] [Related]
29. Transcriptomics and metabolomics reveal the adaption of Akkermansia muciniphila to high mucin by regulating energy homeostasis. Liu X; Zhao F; Liu H; Xie Y; Zhao D; Li C Sci Rep; 2021 Apr; 11(1):9073. PubMed ID: 33907216 [TBL] [Abstract][Full Text] [Related]
30. Nucleotide binding as an allosteric regulatory mechanism for Li CC; Yi H; Wang YM; Tang XY; Zhu YB; Song YJ; Zhao NL; Huang Q; Mou XY; Luo GH; Liu TG; Yang GL; Zeng YJ; Wang LJ; Tang H; Fan G; Bao R Gut Microbes; 2022; 14(1):2143221. PubMed ID: 36394293 [TBL] [Abstract][Full Text] [Related]
31. Geerlings SY; Kostopoulos I; de Vos WM; Belzer C Microorganisms; 2018 Jul; 6(3):. PubMed ID: 30041463 [No Abstract] [Full Text] [Related]
32. Cloning, purification and biochemical characterization of two β-N-acetylhexosaminidases from the mucin-degrading gut bacterium Akkermansia muciniphila. Wang M; Zhang XY; Guo RR; Cai ZP; Hu XC; Chen H; Wei S; Voglmeir J; Liu L Carbohydr Res; 2018 Mar; 457():1-7. PubMed ID: 29304441 [TBL] [Abstract][Full Text] [Related]
33. The evolution and competitive strategies of Kim JS; Kang SW; Lee JH; Park SH; Lee JS Gut Microbes; 2022; 14(1):2025017. PubMed ID: 35263215 [No Abstract] [Full Text] [Related]
34. Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila. Derrien M; Van Baarlen P; Hooiveld G; Norin E; Müller M; de Vos WM Front Microbiol; 2011; 2():166. PubMed ID: 21904534 [TBL] [Abstract][Full Text] [Related]
35. Characterization of a phospholipid-regulated β-galactosidase from Akkermansia muciniphila involved in mucin degradation. Kosciow K; Deppenmeier U Microbiologyopen; 2019 Aug; 8(8):e00796. PubMed ID: 30729732 [TBL] [Abstract][Full Text] [Related]
36. Disease-associated dysbiosis and potential therapeutic role of Akkermansia muciniphila, a mucus degrading bacteria of gut microbiome. Aggarwal V; Sunder S; Verma SR Folia Microbiol (Praha); 2022 Dec; 67(6):811-824. PubMed ID: 35596115 [TBL] [Abstract][Full Text] [Related]
37. Characterizing the mucin-degrading capacity of the human gut microbiota. Glover JS; Ticer TD; Engevik MA Sci Rep; 2022 May; 12(1):8456. PubMed ID: 35589783 [TBL] [Abstract][Full Text] [Related]
38. Aeromonas salmonicida Growth in Response to Atlantic Salmon Mucins Differs between Epithelial Sites, Is Governed by Sialylated and Padra JT; Sundh H; Sundell K; Venkatakrishnan V; Jin C; Samuelsson T; Karlsson NG; Lindén SK Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28533470 [No Abstract] [Full Text] [Related]
39. Mucin as a Functional Niche is a More Important Driver of Van Herreweghen F; De Paepe K; Marzorati M; Van de Wiele T Appl Environ Microbiol; 2021 Mar; 87(4):. PubMed ID: 33277271 [No Abstract] [Full Text] [Related]
40. Display of the human mucinome with defined O-glycans by gene engineered cells. Nason R; Büll C; Konstantinidi A; Sun L; Ye Z; Halim A; Du W; Sørensen DM; Durbesson F; Furukawa S; Mandel U; Joshi HJ; Dworkin LA; Hansen L; David L; Iverson TM; Bensing BA; Sullam PM; Varki A; Vries E; de Haan CAM; Vincentelli R; Henrissat B; Vakhrushev SY; Clausen H; Narimatsu Y Nat Commun; 2021 Jul; 12(1):4070. PubMed ID: 34210959 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]